StockNews.com initiated coverage on shares of Aspira Women’s Health (NASDAQ:AWH – Free Report) in a research note issued to investors on Sunday morning. The brokerage issued a hold rating on the stock.
Aspira Women’s Health Price Performance
AWH stock opened at $0.09 on Friday. Aspira Women’s Health has a 12 month low of $0.08 and a 12 month high of $3.63. The firm’s 50-day moving average is $0.16 and its 200 day moving average is $0.53. The company has a market capitalization of $2.79 million, a PE ratio of -0.08 and a beta of 2.01.
Aspira Women’s Health (NASDAQ:AWH – Get Free Report) last issued its earnings results on Thursday, March 27th. The company reported ($0.08) EPS for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.13. The company had revenue of $2.35 million for the quarter, compared to analysts’ expectations of $3.00 million.
Hedge Funds Weigh In On Aspira Women’s Health
Aspira Women’s Health Company Profile
Aspira Women’s Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.
Further Reading
- Five stocks we like better than Aspira Women’s Health
- What is a buyback in stocks? A comprehensive guide for investors
- Beware of BigBear.ai: Insiders Are Selling—Should You?
- What is the Euro STOXX 50 Index?
- CrowdStrike Stock is a Buy as Cyberthreat Environment Expands
- 5 Top Rated Dividend Stocks to Consider
- Congress! Who Traded What During the Tariff-Induced Meltdown
Receive News & Ratings for Aspira Women's Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspira Women's Health and related companies with MarketBeat.com's FREE daily email newsletter.